These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38135030)

  • 21. The Polish Intestinal Failure Centres' consensus on the use of teduglutide for the treatment of short bowel syndrome.
    Klek S; Kunecki M; Sobocki J; Matysiak K; Karwowska K; Urbanowicz K
    Nutrition; 2017 Jun; 38():28-33. PubMed ID: 28526379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved Outcomes Associated With Teduglutide Use in Patients With Both Short Bowel Syndrome and Crohn's Disease.
    Siu RK; Karime C; Hashash JG; Kinnucan J; Picco MF; Farraye FA
    Crohns Colitis 360; 2024 Jan; 6(1):otae007. PubMed ID: 38352117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of home parenteral nutrition in 251 children over a 14-y period: report of a single center.
    Abi Nader E; Lambe C; Talbotec C; Pigneur B; Lacaille F; Garnier-Lengliné H; Petit LM; Poisson C; Rocha A; Corriol O; Aigrain Y; Chardot C; Ruemmele FM; Colomb-Jung V; Goulet O
    Am J Clin Nutr; 2016 May; 103(5):1327-36. PubMed ID: 27030532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome.
    Carter BA; Cohran VC; Cole CR; Corkins MR; Dimmitt RA; Duggan C; Hill S; Horslen S; Lim JD; Mercer DF; Merritt RJ; Nichol PF; Sigurdsson L; Teitelbaum DH; Thompson J; Vanderpool C; Vaughan JF; Li B; Youssef NN; Venick RS; Kocoshis SA
    J Pediatr; 2017 Feb; 181():102-111.e5. PubMed ID: 27855998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
    Pevny S; Maasberg S; Rieger A; Karber M; Blüthner E; Knappe-Drzikova B; Thurmann D; Büttner J; Weylandt KH; Wiedenmann B; Müller VA; Bläker H; Pascher A; Pape UF
    Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
    Jeppesen PB; Pertkiewicz M; Messing B; Iyer K; Seidner DL; O'keefe SJ; Forbes A; Heinze H; Joelsson B
    Gastroenterology; 2012 Dec; 143(6):1473-1481.e3. PubMed ID: 22982184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
    Kochar B; Long MD; Shelton E; Young L; Farraye FA; Yajnik V; Herfarth H
    J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Teduglutide in Children With Intestinal Failure: A Systematic Review.
    Gigola F; Cianci MC; Cirocchi R; Ranucci MC; Del Riccio M; Coletta R; Morabito A
    Front Nutr; 2022; 9():866518. PubMed ID: 35774551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
    Iyer KR; Kunecki M; Boullata JI; Fujioka K; Joly F; Gabe S; Pape UF; Schneider SM; Virgili Casas MN; Ziegler TR; Li B; Youssef NN; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):946-951. PubMed ID: 27875291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Teduglutide on Diarrhea in Pediatric Patients with Short Bowel Syndrome-Associated Intestinal Failure.
    Fifi A; Raphael BP; Terreri B; Uddin S; Kaufman SS
    J Pediatr Gastroenterol Nutr; 2023 Nov; 77(5):666-671. PubMed ID: 37889619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of teduglutide in pediatric patients with short bowel syndrome: Markov modeling using traditional cost-effectiveness criteria.
    Raghu VK; Rudolph JA; Smith KJ
    Am J Clin Nutr; 2021 Jan; 113(1):172-178. PubMed ID: 33021637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost analysis of chronic intestinal failure.
    Canovai E; Ceulemans LJ; Peers G; De Pourcq L; Pijpops M; De Hertogh G; Hiele M; Pirenne J; Vanuytsel T
    Clin Nutr; 2019 Aug; 38(4):1729-1736. PubMed ID: 30115462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Teduglutide in Infants and Children With Short Bowel Syndrome Dependent on Parenteral Support.
    Chiba M; Masumoto K; Kaji T; Matsuura T; Morii M; Fagbemi A; Hill S; Pakarinen MP; Protheroe S; Urs A; Chen ST; Sakui S; Udagawa E; Wada M
    J Pediatr Gastroenterol Nutr; 2023 Sep; 77(3):339-346. PubMed ID: 37364133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
    Jeppesen PB; Gilroy R; Pertkiewicz M; Allard JP; Messing B; O'Keefe SJ
    Gut; 2011 Jul; 60(7):902-14. PubMed ID: 21317170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of quality of life and caregiver burden in home parenteral nutrition patients: A cross sectional study.
    Beurskens-Meijerink J; Huisman-de Waal G; Wanten G
    Clin Nutr ESPEN; 2020 Jun; 37():50-57. PubMed ID: 32359755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Teduglutide in short bowel syndrome patients: A way back to normal life?
    Harpain F; Schlager L; Hütterer E; Dawoud C; Kirchnawy S; Stift J; Krotka P; Stift A
    JPEN J Parenter Enteral Nutr; 2022 Feb; 46(2):300-309. PubMed ID: 34614239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data.
    Ramos Boluda E; Redecillas Ferreiro S; Manrique Moral O; García Romero R; Irastorza Terradillos I; Nuñez Ramos R; Germán Díaz M; Polo Miquel B; Vives Piñera I; Alcolea Sánchez A; González Sacristán R; Bautista Barea M; Moreno Villares JM
    J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):734-739. PubMed ID: 32804906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining the pathophysiology of short bowel syndrome and glucagon-like peptide 2 analogue suitability in chronic intestinal failure: experience from a national intestinal failure unit.
    Bond A; Taylor M; Abraham A; Teubner A; Soop M; Carlson G; Lal S
    Eur J Clin Nutr; 2019 May; 73(5):751-756. PubMed ID: 30111847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series.
    Ukleja A; To C; Alvarez A; Lara LF
    JPEN J Parenter Enteral Nutr; 2018 May; 42(4):821-825. PubMed ID: 29603279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.
    Seidner DL; Gabe SM; Lee HM; Olivier C; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2020 May; 44(4):697-702. PubMed ID: 31423614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.